Indian Journal of Urology
REVIEW ARTICLE
Year
: 2008  |  Volume : 24  |  Issue : 1  |  Page : 10--15

Prognostic biomarkers of renal cell carcinoma: Recent advances


Hiroshi Kitamura, Taiji Tsukamoto 
 Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan

Correspondence Address:
Hiroshi Kitamura
Department of Urology, Sapporo Medical University School of Medicine, South 1 West 16, Chuo-ku, Sapporo 060-8543
Japan

Recent advances in understanding the characteristics of renal cell carcinoma (RCC) have brought to our attention many prognostic markers that affect and predict the survival outcome of patients with the disease. For the moment, however, patients with RCC have not received any benefit from such markers. If a patient is diagnosed as DQhigh riskDQ by using such prognostic markers, there is no promising systemic therapy available. In this review we mainly focus on biomarkers of RCC that can be applied for therapeutic use reported in recent publications. Several issues and limitations in the reported studies are also highlighted and discussed. Developing biomarkers from the viewpoint of therapeutic application will lead to improvement of the prognosis of RCC patients.


How to cite this article:
Kitamura H, Tsukamoto T. Prognostic biomarkers of renal cell carcinoma: Recent advances.Indian J Urol 2008;24:10-15


How to cite this URL:
Kitamura H, Tsukamoto T. Prognostic biomarkers of renal cell carcinoma: Recent advances. Indian J Urol [serial online] 2008 [cited 2019 Nov 12 ];24:10-15
Available from: http://www.indianjurol.com/article.asp?issn=0970-1591;year=2008;volume=24;issue=1;spage=10;epage=15;aulast=Kitamura;type=0